AGAP2-AS1 and colorectal carcinoma: It has been found that PUNISHER could promote CRC cell proliferation, migration, and epithelial-to-mesenchymal transition, inhibit apoptosis, and enhance the chemoresistance of CRC cells to gemcitabine [10,11].